Musculoskeletal Science and Practice,
Journal Year:
2023,
Volume and Issue:
67, P. 102856 - 102856
Published: Sept. 6, 2023
Paracetamol
is
widely
used
for
low
back
pain
(LBP),
but
research
questions
its
efficacy
and
safety.
Patient
education
booklets
have
been
explored
promoting
deprescribing,
barriers
facilitators
specific
to
LBP
deprescribing
remain
unexamined.
Innovation in Aging,
Journal Year:
2025,
Volume and Issue:
9(2)
Published: Jan. 1, 2025
Polypharmacy,
the
concurrent
use
of
multiple
medicines,
is
a
growing
concern
among
older
adults
and
those
with
chronic
conditions.
Deprescribing
through
dose
reduction
or
discontinuing
selected
medicines
strategy
for
reducing
medicine-related
harm.
The
Patient
Typology
was
developed
using
qualitative
methods
to
describe
varying
factors
that
are
important
when
they
consider
deprescribing.
objective
this
study
quantitative
define
distinct
classes
via
Typology.
This
used
cross-sectional
experimental
design
in
which
data
collected
an
online
survey
from
participants
65
years
Australia,
Netherlands,
United
Kingdom,
States.
A
latent
class
analysis
performed
4-item
about
beliefs
importance
how
learn
medicine
decision-making
preferences,
attitudes
towards
stopping
medicines.
Older
(n
=
2,250)
were
median
70
2-thirds
reported
their
highest
level
education
associate's
degree
trade
school
less.
We
identified
4
classes:
Class
1
"Trusts
doctor"
(41.6%),
2
"Makes
own
decisions"
(30.2%),
3
"Avoids
deprescribing"
(15.5%),
'Medicines
not
important'
(12.7%).
report
diverse
perspectives
deprescribing,
emphasizing
need
tailored
communication
strategies
clinical
settings.
Additional
research
needed
examine
adults'
preferences
real-world
contexts
refine
improve
deprescribing
interventions.
NCT04676282.
Drugs & Aging,
Journal Year:
2022,
Volume and Issue:
39(3), P. 209 - 221
Published: Feb. 21, 2022
Benefits
and
risks
of
preventive
medication
change
over
time
for
ageing
patients
deprescribing
may
be
needed.
Deprescribing
cardiovascular
antidiabetic
drugs
can
challenging
is
not
widely
implemented
in
daily
practice.The
aim
this
study
was
to
identify
barriers
enablers
cardiometabolic
as
seen
by
healthcare
providers
(HCPs)
different
disciplines,
explore
their
views
on
specific
roles
the
process
deprescribing.Three
focus
groups
with
five
general
practitioners,
eight
pharmacists,
three
nurse
two
geriatricians,
elder
care
physicians
were
conducted
cities
The
Netherlands.
Interviews
recorded
transcribed
verbatim.
Directed
content
analysis
performed
basis
Theoretical
Domains
Framework.
Two
researchers
independently
coded
data.Most
HCPs
agreed
that
relevant
but
include
lack
evidence
expertise,
negative
beliefs
fears,
poor
communication
collaboration
between
HCPs,
resources.
Having
a
guideline
considered
an
enabler
medication.
Some
feared
consequences
discontinuing
or
medication,
while
others
motivated
deprescribe
when
experienced
no
problems
all
disciplines
stated
adequate
patient
involving
relatives
decision
making
enables
deprescribing.
Barriers
included
use
initiated
specialists,
exchange
information,
amount
it
takes
uncertain
about
each
other's
responsibilities.
A
multidisciplinary
approach
including
pharmacist
practitioner
best
way
support
address
related
resources.HCPs
recognized
importance
medical
only
made
close
cooperation
patient.
To
successfully
accomplish
they
strongly
recommended
approach.
BMC Geriatrics,
Journal Year:
2021,
Volume and Issue:
21(1)
Published: June 16, 2021
Overtreatment
with
cardiometabolic
medication
in
older
patients
can
lead
to
major
adverse
events.
Timely
deprescribing
of
these
medications
is
therefore
essential.
Self-reported
willingness
stop
usually
high
among
people,
still
overtreatment
common
and
rarely
initiated.
An
important
barrier
for
reported
by
general
practitioners
the
patients'
unwillingness
medication.
More
insights
are
needed
into
influence
characteristics
on
their
attitudes
towards
differences
between
groups.A
survey
people
using
revised
Patients'
Attitudes
Towards
Deprescribing
(rPATD)
questionnaire
was
performed.
Participants
completed
rPATD
an
adapted
version
four
groups.
Linear
ordinal
logistic
regression
were
used
assess
age,
sex,
therapeutic
area
number
deprescribing.
Univariate
analysis
compare
sulfonylureas,
insulins,
antihypertensive
statins.Overall,
314
out
1143
invited
participants
(median
age
76
years,
54%
female).
Most
(80%)
satisfied
willing
if
doctor
said
it
possible
(88%).
Age,
sex
had
no
Taking
more
than
ten
medicines
significantly
associated
a
higher
perceived
burden.
Antihypertensive
insulin
considered
appropriate
statins,
sulfonylureas
not
favouring
deprescribing.The
majority
one
possible.
Health
care
providers
should
take
account
that
perceive
some
as
other
when
discussing
Diabetic Medicine,
Journal Year:
2022,
Volume and Issue:
39(7)
Published: Feb. 4, 2022
Abstract
Aim
The
aim
of
this
systematic
review
is
to
explore
the
attitudes
older
adults
(≥65
years
old)
and
their
carers
towards
de‐prescribing.
Methods
We
identified
relevant
studies
from
three
databases;
MEDLINE,
CINAHL
Web
Science.
Two
reviewers
(MS,
SS)
independently
extracted
data
each
selected
study
using
a
standardised
self‐developed
extraction
form.
Main
findings
were
summarised
descriptively.
Results
A
total
35
included
in
review.
Of
them,
19
questionnaire
studies,
11
semi‐structured
interviews,
4
focus
groups
1
used
nominal
group
technique
approach.
Most
willing
have
medication
de‐prescribed
if
told
do
so
by
healthcare
professional
(HCP).
Other
factors
that
increased
willingness
de‐prescribing
included;
trust
HCP,
side
effects
inconvenience
medications
as
well
prospect
follow‐up
monitoring
during
In
contrast,
perceived
effectiveness,
unawareness
lack
benefit,
negative
expectations
ageing
fear
preventing
Conclusion
De‐prescribing
an
important
concept
people
given
harm
associated
with
polypharmacy
age
group.
Overall,
are
facilitated
HCP.
However,
there
remain
few
barriers
which
may
need
be
addressed
certain
patients,
through
discussions
between
adults/their
allow
more
effective.
Health Policy,
Journal Year:
2025,
Volume and Issue:
154, P. 105265 - 105265
Published: Feb. 12, 2025
Unsustainably
high
numbers
of
patients
attending
emergency
departments
(ED)
is
a
serious
issue
worldwide,
with
consequences
for
the
quality
and
timeliness
care.
Avoidable
visits,
i.e.
unnecessary
or
that
should
be
dealt
elsewhere,
exacerbate
this
issue.
Most
studies
focussed
on
avoidable
attendances
use
clinical
data
collected
by
hospital
staff,
while
study
relies
survey
from
asked
to
recall
their
last
ED
attendance
reflect
its
necessity.
We
apply
Recursive
Bivariate
Probit
model
quantify
factors
affecting
patients'
perception
an
visit
being
(or
not),
unveiling
how
it
relates
socio-demographic
contextual
factors.
find
who
do
not
trust
General
Practitioner
(GP)
are
less
likely
think
was
avoidable.
The
whether
also
associated
symptoms
experienced,
ethnicity
waiting
time
GP
appointment.
BMJ Open,
Journal Year:
2022,
Volume and Issue:
12(12), P. e061686 - e061686
Published: Dec. 1, 2022
To
synthesise
the
current
knowledge
on
barriers
and
facilitators
to
deprescribing
cardiovascular
medications
(CVMs)
at
levels
of
patients,
informal
caregivers
healthcare
providers
(HCPs).We
conducted
a
systematic
review
studies
exploring/assessing
patient,
caregiver
and/or
HCP
CVMs.Ovid/MEDLINE
Embase
from
January
2003
November
2021.We
performed
deductive
thematic
analysis
based
framework
specific
CVMs
created
by
Goyal
et
al.
We
added
quantification
occurrence
categories
themes
in
selected
articles
identify
resounding
that
indicate
greater
impetus
address
future
research.Most
frequent
for
HCPs
included
uncertainty
due
lack
evidence
regarding
CVM
(in
n=10
studies),
fear
negative
consequences
following
(n=13)
social
influences
(n=14).
A
frequently
reported
facilitator
deprescribing,
especially
patients
caregivers,
was
adverse
drug
events
(n=7).
Another
were
dislike
(n=9).
Necessity
benefit
seen
as
or
similarly
HCPs.The
differences
stress
need
ground
discussions
about
beliefs
preferences
each
stakeholder
implicated
decisions.
Furthermore,
highlights
provide
with
tools
enable
sharing
risks
benefits
ensure
safe
process.CRD42020221973.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: Feb. 11, 2022
Background
Deprescribing
requires
patients'
involvement
and
taking
attitudes
toward
deprescribing
into
account.
To
understand
the
observed
variation
in
these
attitudes,
influence
of
contextual-level
factors,
such
as
country
or
healthcare
setting,
should
be
taken
Methods
We
conducted
a
systematic
review
studies
using
revised
Patients'
Attitudes
Towards
(rPATD)
questionnaire
among
older
adults.
searched
articles
Medline
Embase
up
to
30
June
2021.
PRISMA
guideline
was
used
for
search
process
reporting.
summarized
outcomes
from
rPATD
compared
at
study
population
level
between
high
low-middle-income
countries,
global
regions,
settings
ANOVA
testing.
Correlations
with
mean
age
populations
were
tested.
Associations
individual
patient
extracted
included
summarized.
Results
Sixteen
included.
Percentages
patients
willing
stop
medication
significantly
lower
countries
(<70%
Nepal
Malaysia)
high-income
(>85%
USA,
Australia,
European
countries).
No
significant
differences
when
results
by
region
setting
but
willingness
(>95%)
seen
two
an
inpatient
population.
A
higher
associated
medication.
At
level,
associations
characteristics,
including
demographics
education,
showed
inconsistent
results.
Conclusion
Findings
about
are
influenced
contextual
factors.
Future
research
pay
more
attention
system
well
culture
on
attitudes.